SCHEMBL1757447

SCHEMBL1757447

Cc1c(-c2nnc(Cl)c3ccccc23)c2cc(S(C)(=O)=O)cc(Cl)c2n1CC(=O)O

nearest known ligand 0.53

Predicted protein targets (top 2)

geneUniProtsupporting neighboursconfidence
PTGDR2 Q9Y5Y4 20/20 0.53
AKR1B1 P15121 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1758016 0.91 PTGDR2 (0.52) PTGDR2AKR1B1
SCHEMBL1757970 0.91 PTGDR2 (0.62) PTGDR2
SCHEMBL1758187 0.84 PTGDR2 (0.65) PTGDR2
SCHEMBL1757593 0.80 PTGDR2 (0.60) PTGDR2
SCHEMBL1759473 0.76 PTGDR2 (0.60) PTGDR2AKR1B1
SCHEMBL1757745 0.76 PTGDR2 (0.69) PTGDR2
SCHEMBL1757742 0.74 PTGDR2 (0.72) PTGDR2
SCHEMBL1757395 0.73 PTGDR2 (0.60) PTGDR2AKR1B1
SCHEMBL1757736 0.71 PTGDR2 (0.59) PTGDR2
SCHEMBL1757939 0.71 PTGDR2 (0.76) PTGDR2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20110105509-A1 INDOLE BASED RECEPTOR CRTH2 ANTAGONISTS WYETH, LLC (US) 2011-05-05 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110105509-A1 INDOLE BASED RECEPTOR CRTH2 ANTAGONISTS HRH2, CRHR2, CRHR1 PTGDR2 13/4885AKR1B1 475/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.